Published in Health Care Women Int on March 01, 2004
Community-based participatory research (CBPR) in South Africa: engaging multiple constituents to shape the research question. Soc Sci Med (2005) 2.95
Cervical cancer attitudes and beliefs-a Cape Town community responds on World Cancer Day. J Cancer Educ (2009) 1.64
Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ (2007) 1.39
Cervical cancer screening: Current knowledge & practice among women in a rural population of Kerala, India. Indian J Med Res (2012) 1.23
The mother-daughter relationship: what is its potential as a locus for health promotion? Health Care Women Int (2006) 1.05
Determinants of acceptance of cervical cancer screening in Dar es Salaam, Tanzania. BMC Public Health (2012) 0.91
Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health (2016) 0.81
Health promotion and cervical cancer in South Africa: why adolescent daughters can teach their mothers about early detection. Health Promot Int (2011) 0.80
Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey. BMC Public Health (2015) 0.75
Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis (2005) 3.50
Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol (2013) 3.12
Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect Dis (2005) 2.42
Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. Am J Epidemiol (2006) 2.28
Treatment of cancer in sub-Saharan Africa. Lancet Oncol (2013) 2.07
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol (2006) 2.04
The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer (2009) 1.97
Primary care delays in diagnosing cancer: what is causing them and what can we do about them? J R Soc Med (2013) 1.57
Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer (2011) 1.40
Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women. AIDS (2010) 1.36
Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection. J Virol (2008) 1.31
Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis (2006) 1.25
Rape and HIV post-exposure prophylaxis: addressing the dual epidemics in South Africa. Reprod Health Matters (2003) 1.23
Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract. Immunology (2009) 1.21
Intravaginal practices, HIV and other sexually transmitted diseases among South African women. Sex Transm Dis (2004) 1.18
High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol (2003) 1.12
Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. J Infect Dis (2011) 1.04
More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis (2006) 1.03
Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa. J Med Virol (2008) 1.01
Direct comparison of liquid-based and conventional cytology in a South African screening trial. Int J Cancer (2006) 0.98
Cervical cancer prevention for all the world's women: new approaches offer opportunities and promise. Diagn Cytopathol (2007) 0.95
Sexual and reproductive health and HIV services: integrating HIV/AIDS and cervical cancer prevention and control. Int J Gynaecol Obstet (2013) 0.93
Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa. BMC Med (2010) 0.93
Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer (2007) 0.93
Polyclonal expansion of cervical cytobrush-derived T cells to investigate HIV-specific responses in the female genital tract. Immunology (2009) 0.91
Stability and transport of cervical cytobrushes for isolation of mononuclear cells from the female genital tract. J Immunol Methods (2011) 0.91
Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer. J Med Virol (2005) 0.90
Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected women. J Immunol Methods (2010) 0.89
Persistence of genital tract T cell responses in HIV-infected women on highly active antiretroviral therapy. J Virol (2010) 0.88
FIGO Cancer Report 2012. Int J Gynaecol Obstet (2012) 0.87
Use of visual screening methods for cervical cancer screening. Obstet Gynecol Clin North Am (2002) 0.87
Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town. S Afr Med J (2010) 0.86
Recurrence of symptomatic bacterial vaginosis 12 months after oral metronidazole therapy in HIV-positive and -negative women. J Infect Dis (2006) 0.85
Cancer of the cervix uteri. Int J Gynaecol Obstet (2012) 0.85
A comparison of human papillomavirus testing of clinician-collected and self-collected samples during follow-up after screen-and-treat. Int J Cancer (2011) 0.85
HIV-specific T-cell responses detected in the genital tract of chronically HIV-infected women are largely monofunctional. Immunology (2013) 0.84
Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa. PLoS One (2012) 0.84
The agreement between cervical abnormalities identified by cytology and detection of high-risk types of human papillomavirus. S Afr Med J (2006) 0.82
Sister Society Meeting on Global Education Development and Collaboration: Meeting Report. Int J Gynecol Cancer (2016) 0.81
Hereditary gynecologic cancers. Int J Gynaecol Obstet (2013) 0.80
Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease. J Gen Virol (2008) 0.80
Alliance for cervical cancer prevention: setting the record straight. Am J Public Health (2006) 0.80
CD57 expression by T cells in the female genital tract of HIV-zx1 infected women. Clin Immunol (2010) 0.79
Safety of HPV vaccination: a FIGO statement. Int J Gynaecol Obstet (2013) 0.78
Supply and demand challenges to modern contraceptive use in Azerbaijan. Eur J Contracept Reprod Health Care (2007) 0.78
Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study. Acta Obstet Gynecol Scand (2003) 0.76
Gestational trophoblastic neoplasia and human immunodeficiency virus infection: a 10-year review. Int J Gynecol Cancer (2011) 0.75
Performance of an Human Papillomavirus Test in Samples From Women With Histolopathologically Confirmed Invasive Cervical Cancer. J Low Genit Tract Dis (2016) 0.75
Screening for gynaecological cancers. Preface. Best Pract Res Clin Obstet Gynaecol (2012) 0.75
Human papillomavirus genotypes and clinical management of genital warts in women attending a colposcopy clinic in Cape Town, South Africa. S Afr Med J (2015) 0.75